In the News

Share
1714 News Items found
Cody holds his graduation cap
Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer 
Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.
In the Clinic
Drawing of hospital building.
A Future Cancer Hospital in NYC to Meet Rising Need
Learn about MSK's visionary plans for meeting the upcoming surge in cancer cases with state-of-the-art clinical care.
See MSK President and CEO Selwyn Vickers, MD
A Message From Dr. Selwyn Vickers, MSK’s President and CEO
Dear MSK Community,Our knowledge of cancer — what it is and how it progresses — has developed at a staggering pace over the past 20 years. Today, ...
MSK patient Dana Vergara smiles as she holds her baby Hudson.
Baby Hudson Makes History
Learn about Dana and the uterine transposition surgery at MSK in NYC, that enabled her to give birth to a baby named Hudson, who made history.
Harini Veeraraghavan stands in front of a radiology display
How MSK Doctors Are Improving Radiation Treatments With AI
Dr. Harini Veeraraghavan's lab is leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
Gail Goode
How MSK Is Increasing Diversity in Cancer Clinical Trials to Improve Treatments
An MSK clinical trial is helping Gail Goode overcome multiple myeloma and sheds new light on how cancer affects people of diverse ethnic backgrounds.
MSK thoracic surgeon Prasad Adusumilli talking to patient.
How MSK Is Teaching CAR T Cells to Attack Solid Tumors
Read about the latest MSK research to make CAR T therapy effective against solid tumors.
Anaeze Offodile, MD is seen smiling
Meet Our Chief Strategy Officer, Anaeze Offodile, MD
Learn about the Chief Strategy Officer at MSK, Anaeze Offodile, MD, MPH.
A researcher working in an MSK lab
MSK Research Highlights, September 3, 2024
New MSK research uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and risks of commercial genetic testing.
Photo Essay: Training Cancer’s Future Leaders
This photo essay showcases the critical role trainees play within MSK's research enterprise.